Lead author Professor Sunil Badve, Professorial Fellow at The George Institute for Global Health and UNSW Sydney said the study expanded current knowledge about this class of drugs in key areas ...

The study shows that ED drugs, Cialis and Viagra, may reduce the risk of cardiovascular events such as heart attack and stroke and may lower the risk of dementia. ABC's medical group added that an ...

In the RESILIENT SMA study, taldefgrobep showed clinically meaningful ... Also Read: Biohaven Stock Spikes After Drug Candidate To Treat Rare Neurodegenerative Disease Shows Promise Signals ...

SAVA stock plunged Monday after the company released topline data from the Phase 3 ReThink-ALZ study of simufilam in ... fabricating data from simufilam drug trials. In September, Cassava Sciences ...

changes in pharmacokinetics and pharmacodynamics with age, and useful pharmacological treatments for acute pain in older adults. It then presents a few representative cases of pain management in ...

Zealand Pharma A/S said moderate doses of its experimental weight-loss drug helped patients pare pounds ... at 4.8 milligrams experienced nausea in a study, the Danish biotech said Tuesday at ...

AbbVie said a recently acquired drug candidate for schizophrenia missed the key goal in mid-stage studies, pushing its stock sharply lower. Phase 2 studies for emraclidine failed to show a ...

What’s an example of a well-executed drug launch? Look no further than Reata’s commercialization of Skyclarys, the first treatment for the rare degenerative disease Friedreich’s ataxia (FA).

However, limited knowledge exists regarding the actual duration of drug effectiveness and the factors influencing treatment response. In the medical literature, there are currently no Brazilian ...